Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
- 1 September 2016
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 511 (2) , 794-803
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland (252215, 281300)
- University of Helsinki Research Funds
- Biocentrum Helsinki,
- European Research Council (310892)
- Tekes Large Strategic Research
This publication has 62 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Mechanical Properties of Poly(dimethylsiloxane)-block-poly(2-methyloxazoline) Polymersomes Probed by Atomic Force MicroscopyLangmuir, 2012
- Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and BiodistributionMolecular Pharmaceutics, 2012
- Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networksInternational Journal of Nanomedicine, 2011
- Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain gliomaBiomaterials, 2011
- Biomimetic Doxorubicin Loaded Polymersomes from Hyaluronan-block-Poly(γ-benzyl glutamate) CopolymersBiomacromolecules, 2009
- A Three‐Enzyme Cascade Reaction through Positional Assembly of Enzymes in a Polymersome NanoreactorChemistry – A European Journal, 2009
- Micelles and nanoparticles for ultrasonic drug and gene deliveryAdvanced Drug Delivery Reviews, 2008
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free FormDrug Safety, 2001